Opponent control of reinforcement by striatal dopamine and serotonin
- PMID: 39586475
- DOI: 10.1038/s41586-024-08412-x
Opponent control of reinforcement by striatal dopamine and serotonin
Abstract
The neuromodulators dopamine (DA) and serotonin (5-hydroxytryptamine; 5HT) powerfully regulate associative learning1-8. Similarities in the activity and connectivity of these neuromodulatory systems have inspired competing models of how DA and 5HT interact to drive the formation of new associations9-14. However, these hypotheses have not been tested directly because it has not been possible to interrogate and manipulate multiple neuromodulatory systems in a single subject. Here we establish a mouse model that enables simultaneous genetic access to the brain's DA and 5HT neurons. Anterograde tracing revealed the nucleus accumbens (NAc) to be a putative hotspot for the integration of convergent DA and 5HT signals. Simultaneous recording of DA and 5HT axon activity, together with genetically encoded DA and 5HT sensor recordings, revealed that rewards increase DA signalling and decrease 5HT signalling in the NAc. Optogenetically dampening DA or 5HT reward responses individually produced modest behavioural deficits in an appetitive conditioning task, while blunting both signals together profoundly disrupted learning and reinforcement. Optogenetically reproducing DA and 5HT reward responses together was sufficient to drive the acquisition of new associations and supported reinforcement more potently than either manipulation did alone. Together, these results demonstrate that striatal DA and 5HT signals shape learning by exerting opponent control of reinforcement.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: N.E. is a consultant for Boehringer Ingelheim. B.S.B. is a co-founder of Magnus Medical. R.C.M. is on the scientific advisory boards of MapLight Therapeutics, MindMed, Bright Minds Biosciences and Aelis Farma. D.F.C.P., M.B.P., M.Y.G., G.C.T. and A.P.F.C. declare no competing interests.
Similar articles
-
Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement.Elife. 2018 Oct 30;7:e39945. doi: 10.7554/eLife.39945. Elife. 2018. PMID: 30373717 Free PMC article.
-
Chronic stress deficits in reward behaviour co-occur with low nucleus accumbens dopamine activity during reward anticipation specifically.Commun Biol. 2024 Aug 9;7(1):966. doi: 10.1038/s42003-024-06658-9. Commun Biol. 2024. PMID: 39123076 Free PMC article.
-
Orphan receptor-GPR52 inverse agonist efficacy in ameliorating chronic stress-related deficits in reward motivation and phasic accumbal dopamine activity in mice.Transl Psychiatry. 2024 Sep 7;14(1):363. doi: 10.1038/s41398-024-03081-w. Transl Psychiatry. 2024. PMID: 39242529 Free PMC article.
-
Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.Behav Brain Res. 2002 Dec 2;137(1-2):3-25. doi: 10.1016/s0166-4328(02)00282-6. Behav Brain Res. 2002. PMID: 12445713 Review.
-
The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.Prog Neurobiol. 1996 Aug;49(5):455-79. doi: 10.1016/0301-0082(96)00027-5. Prog Neurobiol. 1996. PMID: 8895996 Review.
Cited by
-
Mechanisms of acupuncture in treating depression: a review.Chin Med. 2025 Mar 3;20(1):29. doi: 10.1186/s13020-025-01080-7. Chin Med. 2025. PMID: 40033393 Free PMC article. Review.
-
Differential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans: A Systematic Review and Meta-Analysis.JAMA Psychiatry. 2025 Aug 1;82(8):818-829. doi: 10.1001/jamapsychiatry.2025.0839. JAMA Psychiatry. 2025. PMID: 40498519 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases